CHINA PHARMA HOLDINGS INC (CPHI) Stock Income Statement
NYSEARCA:CPHI - American Stock Exchange - US16941T3023 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.55M | 7.01M | 8.10M | 9.64M | 10.87M | |||
| Cost Of Goods | 7.45M | 7.29M | 8.60M | 9.29M | 8.91M | |||
| Gross Profit | -1.90M | -281.00K | -494.00K | 349.00K | 1.95M | |||
| Operating Expenses | 2.67M | 2.47M | 3.05M | 3.21M | 4.53M | |||
| Research and Development | 430.94K | 240.00K | 186.00K | 319.00K | 378.00K | |||
| Selling, General, and Administrative Expenses | 1.87M | 2.01M | 2.83M | 2.85M | 4.15M | |||
| Operating Income | -4.58M | -2.75M | -3.55M | -2.86M | -2.58M | |||
| Interest Income/Expense | -167.26K | -327.00K | -424.00K | -539.00K | -288.00K | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | 0.00 | |||
| Income Before Taxes | -4.74M | -3.08M | -3.97M | -3.40M | -2.87M | |||
| Income Tax | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Net Income | -4.74M | -3.08M | -3.97M | -3.40M | -2.87M | |||
| EBITDA | -1.71M | 2.00K | -848.00K | 227.00K | 101.00K | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.39 | -0.91 | -3.78 | -3.68 | -3.29 | |||
| Statistics | ||||||||
| Gross Profit Margin | -34.34% | -4.01% | -6.10% | 3.62% | 17.97% | |||
| Profit Margin | -85.55% | -43.92% | -49.03% | -35.25% | -26.39% | |||
| Operating Profit Margin | -82.54% | -39.25% | -43.79% | -29.67% | -23.73% | |||
All data in USD